Jefferies leading push to raise up to $1B for U.S. drug packaging surge capacity
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Jefferies is leading an initiative to raise as much as $1 billion to support HHS’s newly launched public-private partnership to build U.S.-based manufacturing capacity to rapidly produce hundreds of millions of prefilled medical-grade syringes.
HHS launched Rapid Aseptic Packaging of Injectable Drugs (RAPID) last week to enable the Strategic National Stockpile to quickly fill and finish hundreds of millions of prefilled syringes to respond to emerging health threats such as COVID-19. ...